Medication info

Invis Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Intro Biopharma Co., Ltd.
Appearance
White, round, film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201902219 · Approved 2019.04.11

This product's status changed to Expired on 2024.04.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable also to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Intro Biopharma Co., Ltd.

Efficacy & effects

Treatment of gastric acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux
  • Mendelson syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs.
View approved original text

This medication is effective for various gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux. It is also used to treat conditions like Zollinger-Ellison syndrome, associated with excessive gastric acid secretion, and aids in the prevention of Mendelson syndrome during preoperative anesthesia. Moreover, it can manage ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). Therefore, this medicine is widely used in the treatment of gastrointestinal-related disorders.

How to take

Adult dose

○ Adults Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable also to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients with impaired kidney function or patients undergoing dialysis. It should not be administered to individuals allergic to this drug or its components. Patients with a history of acute porphyria should be cautious as this medication may exacerbate symptoms. It is contraindicated in patients who have undergone upper gastrointestinal tract surgery, pregnant women or those who may become pregnant, and premature or newborn infants. Patients on a potassium-restricted diet should also avoid this medication. Caution is warranted in patients with liver dysfunction, previous drug allergies, elderly patients, and those with a history of kidney impairment when using this medication. Special care is required if taken with non-steroidal anti-inflammatory drugs (NSAIDs), and regular monitoring is essential. It may mask symptoms of gastric cancer, thus gastric ulcer patients or middle-aged and older patients with new or changing dyspeptic symptoms should confirm malignancy status before administration. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require eradication therapy. In critically ill patients or those with hypophosphatemia and swallowing difficulties, this medication should be given cautiously due to the risk of side effects. Long-term use of this medication is not recommended, and if no therapeutic effect is observed, switching to another drug is advisable. Elderly patients or those with chronic lung disease, diabetes, or weakened immunity are at increased risk of pneumonia while taking this medication. If dizziness or drowsiness occurs during use, operating vehicles or heavy machinery should be avoided. This medication may interact with other drugs, so it is essential to inform healthcare providers of all medications being taken, especially anticoagulants, for careful monitoring of blood coagulation status. Pregnant or breastfeeding women should not use this medication, and safety in children has not been established, so its use is not recommended. In cases of overdose, measures such as vomiting or gastric lavage may be necessary, and removal can be achieved by blood dialysis if required. This drug may reduce gastric acid secretion and promote bacterial growth in the gastrointestinal tract, so long-term use may necessitate ophthalmologic examinations.

Side effects

  • anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • bone marrow suppression
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • cholestatic hepatitis
  • non-cholestatic hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sensation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbance
  • myoclonic movements
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the drug’s effectiveness.

Appearance and packaging

Appearance

White, round, film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.